Clinical Trial Update: TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document reports results from a Phase 2 trial of TLK286 in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TLK286

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED